Literature DB >> 32025143

Chronic preoperative corticosteroid use is not associated with surgical site infection following revision total knee arthroplasty.

Safa C Fassihi1, Alex Gu1,2, Dana A Perim1, Chapman Wei1, Seth Stake1, Savyasachi Thakkar3, Anthony S Unger4, Michael P Ast5, Peter K Sculco2.   

Abstract

INTRODUCTION: The objective of this study was to determine whether chronic preoperative corticosteroid use is associated with increased infectious complications following revision total knee arthroplasty (rTKA).
METHODS: A retrospective cohort analysis was conducted using patients from a large national database. Patients were divided into two cohorts based upon chronic steroid usage preoperatively. Infectious complications in the 30-day postoperative period were recorded, and univariate and multivariate analyses were performed.
RESULTS: A total of 10,973 patients were included in this study. No significant difference was observed in surgical site infection rates between patients with and without preoperative steroid use. In multivariate analysis, preoperative steroid use was independently associated with an increased likelihood of septic shock (OR 6.17; p = 0.015) and prolonged length-of-stay (OR 1.57; p = 0.038).
CONCLUSION: Chronic preoperative steroid is not a significant risk factor for surgical site infection following rTKA, but it is independently associated with increased risk of septic shock and prolonged hospital length of stay.
© 2020 Professor P K Surendran Memorial Education Foundation. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Complication; Corticosteroid; Revision; Steroid; Total knee arthroplasty

Year:  2020        PMID: 32025143      PMCID: PMC6997114          DOI: 10.1016/j.jor.2020.01.044

Source DB:  PubMed          Journal:  J Orthop        ISSN: 0972-978X


  22 in total

1.  Multiple prosthetic infections after total joint arthroplasty. Risk factor analysis.

Authors:  C P Luessenhop; L D Higgins; B D Brause; C S Ranawat
Journal:  J Arthroplasty       Date:  1996-10       Impact factor: 4.757

2.  Financial analysis of revision knee surgery based on NHS tariffs and hospital costs: does it pay to provide a revision service?

Authors:  R F Kallala; I S Vanhegan; M S Ibrahim; S Sarmah; F S Haddad
Journal:  Bone Joint J       Date:  2015-02       Impact factor: 5.082

3.  Increasing financial burden of revision total knee arthroplasty.

Authors:  Kayode O Oduwole; Diarmuid C Molony; Ray J Walls; Simi P Bashir; Kevin J Mulhall
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2010-02-11       Impact factor: 4.342

Review 4.  Systematic review on the effect of glucocorticoid use on procoagulant, anti-coagulant and fibrinolytic factors.

Authors:  B van Zaane; E Nur; A Squizzato; V E A Gerdes; H R Büller; O M Dekkers; D P M Brandjes
Journal:  J Thromb Haemost       Date:  2010-11       Impact factor: 5.824

5.  Adverse effects of preoperative steroid use on surgical outcomes.

Authors:  Hishaam Ismael; Mathilda Horst; Maria Farooq; Jack Jordon; Joe H Patton; Ilan S Rubinfeld
Journal:  Am J Surg       Date:  2011-03       Impact factor: 2.565

6.  Risk of subsequent revision after primary and revision total joint arthroplasty.

Authors:  Kevin L Ong; Edmund Lau; Jeremy Suggs; Steven M Kurtz; Michael T Manley
Journal:  Clin Orthop Relat Res       Date:  2010-05-25       Impact factor: 4.176

7.  How Do Preoperative Medications Influence Outcomes After Total Joint Arthroplasty?

Authors:  Bradley J Zarling; Jakub Sikora-Klak; Chris Bergum; David C Markel
Journal:  J Arthroplasty       Date:  2017-04-27       Impact factor: 4.757

8.  Development and Validation of a Preoperative Surgical Site Infection Risk Score for Primary or Revision Knee and Hip Arthroplasty.

Authors:  Joshua S Everhart; Rebecca R Andridge; Thomas J Scharschmidt; Joel L Mayerson; Andrew H Glassman; Stanley Lemeshow
Journal:  J Bone Joint Surg Am       Date:  2016-09-21       Impact factor: 5.284

9.  Current cigarette smoking among adults - United States, 2005-2014.

Authors:  Ahmed Jamal; David M Homa; Erin O'Connor; Stephen D Babb; Ralph S Caraballo; Tushar Singh; S Sean Hu; Brian A King
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-11-13       Impact factor: 17.586

10.  Comprehension of Top 200 Prescribed Drugs in the US as a Resource for Pharmacy Teaching, Training and Practice.

Authors:  Andrea V Fuentes; Moises D Pineda; Kalyan C Nagulapalli Venkata
Journal:  Pharmacy (Basel)       Date:  2018-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.